Arjun Rustagi is an Infectious Disease physician affiliated with University of California, San Francisco. OpenAlex indexes 65 publications with 5,217 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 16 Apr 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
University of California, San Francisco
FY2025$192,509K08AI163369 - Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
University of California, San Francisco
FY2024$175,510K08AI163369 - Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
Stanford University
FY2024$17,810K08AI163369
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection
Science Translational Medicine
2025 - First, do NOHARM: a medical safety benchmark and randomized study of physician and AI teaming on clinical consultations
arXiv (Cornell University)
2025 - Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung
The Journal of Experimental Medicine
2024 - An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Science Translational Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”